This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Aummune Ltd.. Active years: 2024.
Company Filing History:
Years Active: 2024
Title: Irit Carmi-Levy: Innovator in T-Lymphocyte Binding Aptamers
Introduction
Irit Carmi-Levy is a prominent inventor based in Tel Aviv, Israel. She has made significant contributions to the field of biotechnology, particularly in the development of aptamers that target T-lymphocytes. Her innovative work has the potential to impact various therapeutic applications.
Latest Patents
Irit holds a patent for T-lymphocyte binding aptamers. This patent provides methods and compositions that target T-lymphocytes, which are crucial components of the immune system. The patent is a testament to her expertise and dedication to advancing medical science. She has 1 patent to her name.
Career Highlights
Irit is currently associated with Aummune Ltd., a company focused on developing novel immunotherapies. Her role at Aummune allows her to collaborate with other experts in the field and contribute to groundbreaking research.
Collaborations
Irit has worked alongside notable colleagues, including Neria Reiss and Zohar Pode. Their combined efforts in research and development have fostered an environment of innovation and creativity.
Conclusion
Irit Carmi-Levy's work in T-lymphocyte binding aptamers exemplifies her commitment to advancing biotechnology. Her contributions are paving the way for new therapeutic strategies in immunology.